ESTA Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

63.87M

+43.48%

-0.223

-81.29%

56.42M

+36.35%

-0.463

-33.85%

64.95M

+26.62%

-0.295

-48.28%

Estimates Revision

The market is revising Upward the revenue expectations for Establishment Labs Holdings Inc. (ESTA) for FY2025, with the revenue forecasts being adjusted by 0.7% over the past three months. During the same period, the stock price has changed by 89.64%.

Revenue Estimates for FY2025

Revise Upward

+0.7%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-12.83%

In Past 3 Month

Stock Price

Go Up

+89.64%

In Past 3 Month

8 Analyst Rating

Wall Street analysts forecast ESTA stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ESTA is 71.75 USD with a low forecast of 43.00 USD and a high forecast of 85.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

7 Buy

1 Hold

0 Sell

Strong Buy

Current: 74.150

Low

43.00

Averages

71.75

High

85.00

Current: 74.150

Low

43.00

Averages

71.75

High

85.00

Citi

Neutral

maintain

$62 -> $75

2025-12-11

Reason

Citi

Price Target

$62 -> $75

2025-12-11

maintain

Neutral

Reason

Citi raised the firm's price target on Establishment Labs to $75 from $62 and keeps a Neutral rating on the shares. The firm adjusted ratings and targets in the medical technology sector as part of its 2026 outlook. The group is "bouncing off its lows," and there is further upside potential in 2026, the analyst tells investors in a research note. Citi believes the S&P Equipment and Supplies index "remains undervalued and underappreciated." The firm expects a rebound next year due to company catalysts and sector rotation.

Needham

NULL

Buy

maintain

$70 -> $84

2025-12-10

Reason

Needham

Price Target

$70 -> $84

2025-12-10

maintain

NULL

Buy

Reason

Needham raised the firm's price target on Establishment Labs to $84 from $70 and keeps a Buy rating on the shares. The company has multiple growth drivers, including US breast augmentation, US breast reconstruction, and its minimally invasive procedures, the analyst tells investors in a research note. Establishment Labs' growth drivers indicates that it should be able to sustain strong double-digit growth for 5 years and beyond, the firm added.

BTIG

Buy

maintain

$70 -> $81

2025-11-14

Reason

BTIG

Price Target

$70 -> $81

2025-11-14

maintain

Buy

Reason

BTIG raised the firm's price target on Establishment Labs to $81 from $70 and keeps a Buy rating on the shares. To get a better idea of Motiva adoption trends and market share shifts over the coming years, the firm conducted a brief poll of 33 U.S. plastic surgeons who perform aesthetic breast augmentations in the week following the company's Q3 earnings call, and the polled surgeons anticipate the market will remain healthy, with procedural volumes expected to increase at a 14% CAGR from 2025-2027, the analyst tells investors in a research note.

JPMorgan

Allen Gong

Overweight

maintain

$45 -> $71

2025-11-06

Reason

JPMorgan

Allen Gong

Price Target

$45 -> $71

2025-11-06

maintain

Overweight

Reason

JPMorgan analyst Allen Gong raised the firm's price target on Establishment Labs to $71 from $45 and keeps an Overweight rating on the shares. The company reported good Q3 results on better profitability, the analyst tells investors in a research note.

Canaccord

Buy

maintain

$60 -> $72

2025-11-06

Reason

Canaccord

Price Target

$60 -> $72

2025-11-06

maintain

Buy

Reason

Canaccord raised the firm's price target on Establishment Labs to $72 from $60 and keeps a Buy rating on the shares. The firm said they posted a strong quarter with top-line results exceeding expectations, growing 34% year-over-year, while achieving its first quarter of EBITDA positivity.

Needham

NULL -> Buy

upgrade

$48 -> $70

2025-11-06

Reason

Needham

Price Target

$48 -> $70

2025-11-06

upgrade

NULL -> Buy

Reason

Needham raised the firm's price target on Establishment Labs to $70 from $48 and keeps a Buy rating on the shares. The company's Q3 revenue and adjusted EBITDA beat consensus, and the management now expects 2025 revenue to exceed the mid-point of its former revenue guidance range, the analyst tells investors in a research note.

Valuation Metrics

The current forward P/E ratio for Establishment Labs Holdings Inc (ESTA.O) is -59.35, compared to its 5-year average forward P/E of -32.76. For a more detailed relative valuation and DCF analysis to assess Establishment Labs Holdings Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-32.76

Current PE

-59.35

Overvalued PE

-14.32

Undervalued PE

-51.19

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-90.86

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

30.58

Undervalued EV/EBITDA

-212.30

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

7.95

Current PS

0.00

Overvalued PS

10.62

Undervalued PS

5.28

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds areSelling! The selling amount has increased 348.78% over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

ESTA News & Events

Events Timeline

No data

News

5.0

11-20NASDAQ.COM

17.0% of FHLC Holdings Experiencing Recent Insider Purchases

9.5

11-17Yahoo Finance

Establishment Labs Holdings (ESTA) Rises Over 27% Following Q3 2025 Earnings Report

4.0

11-14Benzinga

BTIG Reaffirms Buy Rating for Establishment Labs Holdings, Increases Price Target to $81

People Also Watch

Frequently Asked Questions

What is Establishment Labs Holdings Inc (ESTA) stock price today?

The current price of ESTA is 74.15 USD — it has increased 2.94 % in the last trading day.

What is Establishment Labs Holdings Inc (ESTA)'s business?

Establishment Labs Holdings Inc. is Costa Rica-based medical technology and aesthetics company that is focused on women's health reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers.

What is the price predicton of ESTA Stock?

What is Establishment Labs Holdings Inc (ESTA)'s revenue for the last quarter?

Establishment Labs Holdings Inc revenue for the last quarter amounts to 53.78M USD, increased 33.70 % YoY.

What is Establishment Labs Holdings Inc (ESTA)'s earnings per share (EPS) for the last quarter?

Establishment Labs Holdings Inc. EPS for the last quarter amounts to -0.38 USD, decreased -35.59 % YoY.

What changes have occurred in the market's expectations for Establishment Labs Holdings Inc (ESTA)'s fundamentals?

How many employees does Establishment Labs Holdings Inc (ESTA). have?

Establishment Labs Holdings Inc (ESTA) has 1018 emplpoyees as of December 17 2025.

What is Establishment Labs Holdings Inc (ESTA) market cap?

Today ESTA has the market capitalization of 2.15B USD.